Michael Rigney is a Senior Executive Oncology Specialist at AstraZeneca, where they have developed expertise in strategic thinking, technical selling, and leadership since joining in 2015. Previously, they served as a Market Development Specialist at Onyx Pharmaceuticals from 2009 to 2015, focusing on expanding the prescriber base for unresectable Hepatocellular Carcinoma. Michael has also worked as a Senior Specialty Representative at Schering-Plough, specializing in oncology and hepatology. They are currently enrolled in Amgen's Management Development Program, which aims to hone their management skills in coaching, communication, and talent evaluation. Michael holds a B.S. in Finance from Penn State University.
Location
Philadelphia, United States
This person is not in the org chart
This person is not in any teams
This person is not in any offices